SCHEMBL7479352

SCHEMBL7479352

CCC1(CC)OC[C@H](C=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5073759 1.00
SCHEMBL9130929 0.79 TDP1 (0.37)
SCHEMBL13822372 0.79 TDP1 (0.37)
SCHEMBL13001895 0.72
SCHEMBL12976171 0.72
SCHEMBL367022 0.71
SCHEMBL2257240 0.71
SCHEMBL367023 0.71
SCHEMBL6765480 0.71 MMP9 (0.35)
SCHEMBL10618639 0.70 GRIN1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-1222519-C Reverse hydroxamate inhibitors of matrix metalloproteinases ABBOTT LAB (US) 2005-10-12 CN disclosed
EP-1147101-B1 REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LAB (US) 2002-11-20 EP disclosed
EP-1258486-A2 Process for preparing 2,2-difluoroketene silyl o,s-acetals and alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid o,s-esters ELI LILLY AND COMPANY (US) 2002-11-20 EP disclosed
CN-1339032-A Reverse hydroxamate inhibitors of matrix metalloproteinases ABBOTT LAB (US) 2002-03-06 CN disclosed
US-20020007060-A1 Reverse hydroxamate inhibitors of matrix metalloproteinases DAVIDSEN STEVEN K (US) 2002-01-17 US disclosed
EP-0677527-B1 Process for preparing 2,2-difluoroketene silyl O,S-acetals and alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid O,S-esters LILLY CO ELI (US) 2002-01-16 EP disclosed
EP-1147101-A1 REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LABORATORIES (US) 2001-10-24 EP disclosed
US-6294573-B1 FOR THERAPY RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR INVASION ABBOTT LABORATORIES 2001-09-25 US disclosed
EP-0655454-B1 Process for preparing 2,2-difluoroketene silyl acetals and alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid esters LILLY CO ELI (US) 2001-08-16 EP disclosed
WO-2000044739-A1 REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LABORATORIES (US) 2000-08-03 WO disclosed
EP-0970962-A2 Process for preparing 2,2-difluoroketene silyl, 0, S-acetals and alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid 0,S-esters ELI LILLY AND COMPANY (US) 2000-01-12 EP disclosed
US-5618951-A REACTING A CHLORODIFLUOROACETATE WITH A HALOSILANE USING AN UREA SILVENT AND A REDUCING AGENT ELI LILLY AND COMPANY (US) 1997-04-08 US disclosed
EP-0677527-A1 Process for preparing 2,2-difluoroketene silyl O,S-acetals and alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid O,S-esters ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed
US-5428176-A Contacting a difluorothioacetate with a halosilane in presence of reducing agent ELI LILLY AND COMPANY (US) 1995-06-27 US disclosed
EP-0655454-A1 Process for preparing 2,2-difluoroketene silyl acetals and a,a-difluoro-b-silyloxy-1,3-dioxolane-4-propanoic acid esters ELI LILLY AND COMPANY (US) 1995-05-31 EP disclosed